Russell Investments Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.96K | Sell |
4,526
-5,779
| -56% | -$12.7K | ﹤0.01% | 3335 |
|
2025
Q1 | $12K | Sell |
10,305
-37,403
| -78% | -$43.4K | ﹤0.01% | 3211 |
|
2024
Q4 | $60.6K | Sell |
47,708
-3,453
| -7% | -$4.39K | ﹤0.01% | 2783 |
|
2024
Q3 | $174K | Sell |
51,161
-6,458
| -11% | -$22K | ﹤0.01% | 2540 |
|
2024
Q2 | $269K | Buy |
57,619
+44,781
| +349% | +$209K | ﹤0.01% | 2401 |
|
2024
Q1 | $95.3K | Buy |
12,838
+7,648
| +147% | +$56.7K | ﹤0.01% | 2580 |
|
2023
Q4 | $52.6K | Buy |
5,190
+4,156
| +402% | +$42.1K | ﹤0.01% | 2634 |
|
2023
Q3 | $8.07K | Sell |
1,034
-1,353
| -57% | -$10.6K | ﹤0.01% | 3057 |
|
2023
Q2 | $19.6K | Sell |
2,387
-94
| -4% | -$774 | ﹤0.01% | 2843 |
|
2023
Q1 | $18K | Sell |
2,481
-11,864
| -83% | -$86K | ﹤0.01% | 2827 |
|
2022
Q4 | $127K | Sell |
14,345
-23,953
| -63% | -$212K | ﹤0.01% | 2631 |
|
2022
Q3 | $466K | Buy |
38,298
+35,580
| +1,309% | +$433K | ﹤0.01% | 2273 |
|
2022
Q2 | $32K | Buy |
+2,718
| New | +$32K | ﹤0.01% | 2759 |
|
2022
Q1 | – | Sell |
-17,627
| Closed | -$466K | – | 2797 |
|
2021
Q4 | $466K | Sell |
17,627
-17,804
| -50% | -$471K | ﹤0.01% | 2471 |
|
2021
Q3 | $1.45M | Buy |
35,431
+13,614
| +62% | +$559K | ﹤0.01% | 2012 |
|
2021
Q2 | $1.23M | Sell |
21,817
-25,831
| -54% | -$1.46M | ﹤0.01% | 2207 |
|
2021
Q1 | $2M | Sell |
47,648
-9,088
| -16% | -$381K | ﹤0.01% | 1874 |
|
2020
Q4 | $3.99M | Sell |
56,736
-54,562
| -49% | -$3.83M | 0.01% | 1365 |
|
2020
Q3 | $3.12M | Sell |
111,298
-2,894
| -3% | -$81.2K | 0.01% | 1411 |
|
2020
Q2 | $3.38M | Buy |
114,192
+70,288
| +160% | +$2.08M | 0.01% | 1328 |
|
2020
Q1 | $870K | Buy |
+43,904
| New | +$870K | ﹤0.01% | 1912 |
|
2018
Q1 | – | Sell |
-102,075
| Closed | -$3.2M | – | 2929 |
|
2017
Q4 | $3.2M | Buy |
+102,075
| New | +$3.2M | 0.01% | 1579 |
|
2017
Q1 | – | Sell |
-17,647
| Closed | -$284K | – | 3009 |
|
2016
Q4 | $284K | Buy |
+17,647
| New | +$284K | ﹤0.01% | 2633 |
|